Viral Vaccines

Viral vaccines are prepared by using the weakened (attenuated) form of virus. Although vaccines have proven pivotal against arrays of infectious viral diseases, there are still no effective vaccines against many viruses. New structural insights into the viral envelope, protein conformation, and antigenic epitopes can guide the planning of novel vaccines against challenging viruses. Recent studies demonstrated that applications of this structural information can solve a number of the vaccine conundrums. recent advances in structure-based vaccine design, or structural vaccinology, for novel and innovative viral vaccine design and information can solve some of the vaccine conundrums.


  • Live attenuated
  • Inactivated vaccines

Related Conference of Viral Vaccines

June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Viral Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in